Cyclophosphamide (Cytoxan): A review on relevant pharmacology and clinical uses
- 31 December 1984
- journal article
- review article
- Published by Elsevier BV in Journal of the American Academy of Dermatology
- Vol. 11 (6), 1115-1126
- https://doi.org/10.1016/s0190-9622(84)80193-0
Abstract
No abstract availableKeywords
This publication has 103 references indexed in Scilit:
- Effect of Cytotoxic Drugs in Frequently Relapsing Nephrotic Syndrome with and without Steroid DependenceNew England Journal of Medicine, 1982
- Lymphomatoid GranulomatosisNew England Journal of Medicine, 1982
- Effects of combination chemotherapy on immunoregulatory cells in peripheral blood of solid tumor cancer patients: Correlation with rebound overshoot immune function recoveryClinical Immunology and Immunopathology, 1981
- Cyclophosphamide Therapy of Severe Systemic Necrotizing VasculitisNew England Journal of Medicine, 1979
- Treatment of Diffuse Proliferative Lupus Nephritis with Prednisone and Combined Prednisone and CyclophosphamideNew England Journal of Medicine, 1978
- Late-onset pulmonary fibrosis and chest deformity in two children treated with cyclophosphamideThe Journal of Pediatrics, 1978
- Pattern of response to prednisone in idiopathic, minimal lesion nephrotic syndrome as a criterion in selecting patients for cyclophosphamide therapyThe Journal of Pediatrics, 1978
- Normal pregnancy in multiple myeloma treated with cyclophosphamideCancer, 1974
- Pyoderma gangrenosum with response to cyclophosphamide therapyThe Journal of Pediatrics, 1967
- Clinical evaluation of a new alkylating agent: Cytoxan (cyclophosphamide)Cancer, 1960